International Biotechnology

Data as at: 25/01/2021

To achieve capital growth through investing in high growth, development stage biotechnology companies.
Management group
Launch date
United Kingdom

Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.

Total assets (m) Price (last close) Price (bid) Price (offer) NAV Dividend dates Discount / premium (%) Gearing (%) 5yr dividend growth (%) p.a. Dividend yield (%)
339.21 835.00 832.00 838.00 841.34 Jul, Dec -0.8 2 N/A 3.4


Dividends displayed in traded currency.

Ex-Dividend date Dividend amount Dividend type Special dividend Financial year
24/12/2020 14.200 Capital No 2021
16/07/2020 12.400 Capital No 2020

View dividend history

Dividend cover (years) Revenue reserves (m)
N/A -40.98

Trading information

ISIN TIDM Traded currency
GB0004559349 IBT GBX

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 56,894 1,785,907 22,326,336 76,210,672
Average N/A 92,510 88,122 59,790

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 0.48 14.77 160.92 474.85
Average N/A 0.76 0.64 0.37

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.